International Tech Times
SEE OTHER BRANDS

Your science and technology news reporter

International Tech Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.

Press releases published on March 20, 2025

Richtech Robotics and Ghost Kitchens Announce Restaurant Opening at Peachtree City Walmart

Richtech Robotics and Ghost Kitchens Announce Restaurant Opening at Peachtree City Walmart

Georgia supercenter marks third One Kitchen location in collaboration and first to feature Company’s AI-driven Scorpion robot Las Vegas, NV, March 20, 2025 (GLOBE NEWSWIRE) -- Richtech Robotics Inc. (Nasdaq: RR) (“Richtech Robotics”), a Nevada-based …

CorVista Health to Present New Data on Non-Invasive Point of Care Test for Pulmonary Capillary Wedge Pressure Elevation Using Machine Learning at ACC.25

CorVista Health to Present New Data on Non-Invasive Point of Care Test for Pulmonary Capillary Wedge Pressure Elevation Using Machine Learning at ACC.25

BETHESDA, Md., March 20, 2025 (GLOBE NEWSWIRE) -- CorVista Health today announced the upcoming poster presentation of new data on its non-invasive point of care test for pulmonary capillary wedge pressure (PCWP) elevation – a key indicator of heart failure …

Microchip Technology Engages Macquarie Group to Facilitate Sale of Tempe Fab 2 Wafer Fabrication Facility

Microchip Technology Engages Macquarie Group to Facilitate Sale of Tempe Fab 2 Wafer Fabrication Facility

CHANDLER, Ariz., March 20, 2025 (GLOBE NEWSWIRE) -- Microchip Technology (Nasdaq: MCHP) today announced it has engaged Macquarie Group to oversee the marketing and sale of its wafer fabrication facility (“Fab 2”) located in Tempe, Arizona. This decision is …

InFlux Technologies Teams Up with NexGen Cloud to Deliver Hyperstack Solutions Built with NVIDIA AI Accelerated Computing Platform

InFlux Technologies Teams Up with NexGen Cloud to Deliver Hyperstack Solutions Built with NVIDIA AI Accelerated Computing Platform

CAMBRIDGE, United Kingdom, March 20, 2025 (GLOBE NEWSWIRE) -- InFlux Technologies (Flux), a leading global decentralized technology company specializing in cloud infrastructure, artificial intelligence, and decentralized cloud computing services, has …

PBGH Advisory Services Available Nationwide to Provide Fiduciary Support to Employers Sponsoring Health Benefits

PBGH Advisory Services Available Nationwide to Provide Fiduciary Support to Employers Sponsoring Health Benefits

Oakland, California, March 20, 2025 (GLOBE NEWSWIRE) -- Purchaser Business Group on Health (PBGH), a nonprofit coalition representing 40 private employers and public entities across the U.S., today announced general availability of PBGH Advisory Services …

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

LONDON and GAITHERSBURG, Md., March 20, 2025 (GLOBE NEWSWIRE) -- Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg, by Health Canada for the …

Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights

Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights

Achieved Q4 2024 PEMGARDA™ (pemivibart) net product revenue of $13.8 million, representing 48% growth over Q3 2024 net product revenue of $9.3 million; full-year 2024 net product revenue totaled $25.4 million 2024 year-end cash and cash equivalents of $69. …

Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer

Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer

The Data Safety Monitoring Board (DSMB) identified no safety concerns, and recommended continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ plus immune check point inhibitor in metastatic breast cancer The pivotal Phase 3 study is currently under …

Esperion Aligns with U.S. Food and Drug Administration to Initiate Phase 3 Clinical Trials of Bempedoic Acid in Pediatric Heterozygous and Homozygous Familial Hypercholesterolemia

Esperion Aligns with U.S. Food and Drug Administration to Initiate Phase 3 Clinical Trials of Bempedoic Acid in Pediatric Heterozygous and Homozygous Familial Hypercholesterolemia

– Confirms Sufficient Data to Complete Phase 2 Clinical Study Enrollment and Advance to Phase 3 Studies in Both Heterozygous and Homozygous Familial Hypercholesterolemia – – Establishes Pediatric Path Forward to Start and Complete Phase 3 Trial and Secure …

Beyond Identity and Nametag Announce Strategic Partnership to Strengthen Identity & Access Management Using Deepfake Defense™ Identity Verification

Beyond Identity and Nametag Announce Strategic Partnership to Strengthen Identity & Access Management Using Deepfake Defense™ Identity Verification

NEW YORK and SEATTLE, March 20, 2025 (GLOBE NEWSWIRE) -- Beyond Identity, the only access management platform engineered to prevent identity and device-based threats, and Nametag, the leading provider of integrated identity verification and account …

Axonius Unveils Unified Identity Management & Security Solution to Centralize IAM Program Operations

Axonius Unveils Unified Identity Management & Security Solution to Centralize IAM Program Operations

DALLAS, March 20, 2025 (GLOBE NEWSWIRE) -- Axonius, the leader in cyber asset management that delivers visibility and actionability across all digital assets, today announced the launch of Axonius Identities, a first-of-its-kind product backed by asset …

Milestone Pharmaceuticals to Present Clinical Data on Etripamil at the American College of Cardiology

Milestone Pharmaceuticals to Present Clinical Data on Etripamil at the American College of Cardiology

MONTREAL and CHARLOTTE, N.C., March 20, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it …

Nitrase Therapeutics Unveils Protein with Newly Characterized Enzymatic Function Involved in the Pathogenesis of Parkinson’s Disease

Nitrase Therapeutics Unveils Protein with Newly Characterized Enzymatic Function Involved in the Pathogenesis of Parkinson’s Disease

- Glyoxalase Domain-containing Protein 4 (GLOD4), the First Identified in a New Class of Enzymes Called Nitrases, Generates Nitrated Alpha-synuclein, a Hallmark of Parkinson’s Disease (PD) -Company Advancing Both NDC-0524, a Monoclonal Antibody with High …

Medera Receives DSMB Clearance to Initiate Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial for SRD-001 Gene Therapy in Heart Failure with Reduced Ejection Fraction

Medera Receives DSMB Clearance to Initiate Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial for SRD-001 Gene Therapy in Heart Failure with Reduced Ejection Fraction

BOSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on cardiovascular diseases with high unmet need by developing a range of next-generation therapeutics, today announced that the …

Global Uranium and Forum Energy Metals Announce the Commencement of Drilling and Ground Geophysical Surveys on the Northwest Athabasca Project, Saskatchewan

Global Uranium and Forum Energy Metals Announce the Commencement of Drilling and Ground Geophysical Surveys on the Northwest Athabasca Project, Saskatchewan

CALGARY, Alberta, March 20, 2025 (GLOBE NEWSWIRE) -- Global Uranium Corp. (CSE: GURN | OTC: GURFF | FRA: Q3J) (the "Company" or “Global”) and Forum Energy Metals Corp. (TSX.V: FMC; OTCQB: FDCFF) (“Forum”) are pleased to announce that it has commenced its …

BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings

BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings

SAN DIEGO, March 20, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today …

Young Bettors and March Madness Participants Face High Gambling Risks

Young Bettors and March Madness Participants Face High Gambling Risks

TORONTO, March 20, 2025 (GLOBE NEWSWIRE) -- The Responsible Gambling Council’s (RGC) Big Games sports betting survey reveals the vast majority of Ontarians (89 per cent) plan to watch at least one major sporting event this year. Over three quarters (77 per …

Corvus Pharmaceuticals Announces Presentation of Additional Data from the Phase 1/1b Clinical Trial of Soquelitinib for Patients with T Cell Lymphoma

Corvus Pharmaceuticals Announces Presentation of Additional Data from the Phase 1/1b Clinical Trial of Soquelitinib for Patients with T Cell Lymphoma

SOUTH SAN FRANCISCO, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that additional data from the Company’s Phase 1/1b clinical trial of soquelitinib for …

Teledyne’s new 2.5 GigE Vision line scan camera delivers industry-leading performance in a cost-effective package

Teledyne’s new 2.5 GigE Vision line scan camera delivers industry-leading performance in a cost-effective package

WATERLOO, Ontario, March 20, 2025 (GLOBE NEWSWIRE) -- Teledyne DALSA, a Teledyne Technologies [NYSE: TDY] company and global leader in machine vision, announces the new Tetra™ line scan camera family. Designed for a wide range of machine vision …

Cerence AI Adds Former Ford Executive Marion Harris to its Board of Directors

Cerence AI Adds Former Ford Executive Marion Harris to its Board of Directors

BURLINGTON, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that Marion Harris, a long-time Ford Motor Company executive, has been …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service